310
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Conjugation Of EGCG And Chitosan NPs As A Novel Nano-Drug Delivery System

ORCID Icon, , & ORCID Icon
Pages 8033-8046 | Published online: 04 Oct 2019

References

  • Lin YH, Chen ZR, Lai CH, Hsieh CH, Feng CL. Active targeted nanoparticles for oral administration of gastric cancer therapy. Biomacromolecules. 2015;16(9):3021–3032. doi:10.1021/acs.biomac.5b0090726286711
  • Dahiya S, Rani R, Kumar S, Dhingra D, Dilbaghi N. Chitosan-gellan gum bipolymeric nanohydrogels—a potential nanocarrier for the delivery of epigallocatechin gallate. BioNanoScience. 2017;7(3):508–520. doi:10.1007/s12668-017-0416-0
  • Goodrich CP, Brenner MP, Ribbeck K. Enhanced diffusion by binding to the crosslinks of a polymer gel. Nat Commun. 2018;9(1):4348. doi:10.1038/s41467-018-06851-530341303
  • Li P, Wang Y, Peng Z, She F, Kong L. Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends. Carbohydr Polym. 2011;85(3):698–704. doi:10.1016/j.carbpol.2011.03.045
  • Mahanta AK, Senapati S, Paliwal P, Krishnamurthy S, Hemalatha S, Maiti P. Nanoparticle-induced controlled drug delivery using chitosan-based hydrogel and scaffold: application to bone regeneration. Mol Pharmaceutics. 2019;16(1):327–338. doi:10.1021/acs.molpharmaceut.8b00995
  • Xiao B, Zhang Z, Viennois E, et al. combination therapy for ulcerative colitis: orally targeted nanoparticles prevent mucosal damage and relieve inflammation. Theranostics. 2016;6(12):2250–2266. doi:10.7150/thno.1571027924161
  • Granja A, Frias I, Neves AR, Pinheiro M, Reis S. Therapeutic potential of epigallocatechin gallatenanodelivery systems. Biomed Res Int. 2017;2017:5813793. doi:10.1155/2017/581379328791306
  • Granja A, Pinheiro M, Reis S. Epigallocatechin gallatenanodelivery systems for cancer therapy. Nutrients. 2016;8:5. doi:10.3390/nu8050307
  • Zeng L, Yan J, Luo L, Ma M, Zhu H. Preparation and characterization of (-)-Epigallocatechin-3-gallate (EGCG)-loaded nanoparticles and their inhibitory effects on human breast cancer MCF-7 cells. Sci Rep. 2017;7:45521. doi:10.1038/srep4552128349962
  • Yang R, Tian J, Wang D, Blanchard C, Zhou Z. Chitosan binding onto the epigallocatechin loaded ferritin nanocage enhance its transport across Caco-2 cells. Food Funct. 2018;9(4):2015–2024. doi:10.1039/c8fo00097b29541738
  • Bhumkar DR, Joshi HM, Sastry M, Pokharkar VB. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res. 2007;24(8):1415–1426. doi:10.1007/s11095-007-9257-917380266
  • Cafaggi S, Leardi R, Parodi B, Caviglioli G, Russo E, Bignardi G. Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery. J Control Release. 2005;102(1):159–169. doi:10.1016/j.jconrel.2004.09.01915653142
  • Lin YH, Feng CL, Lai CH, Lin JH, Chen HY. Preparation of epigallocatechin gallate-loaded nanoparticles and characterization of their inhibitory effects on Helicobacter pylori growth in vitro and in vivo. Sci Technol Adv Mater. 2014;15(4):045006. doi:10.1088/1468-6996/15/4/04500627877707
  • Available from: http://rsb.info.nih.gov/ij. USA: ImageJ is a public domain Java Image Processing program inspired by NIH. Accessed 2008.
  • Abramoff MD, Magalhaes PJ, Ram SJ. Image processing with image. J Biophotonics Intl. 2004;11:36.
  • Peter B, Bosze S, Horvath R. Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials. EurBiophys J. 2017;46(1):1–24. doi:10.1007/s00249-016-1141-2
  • Hoseinpour V, Ghaemi N. Green synthesis of manganese nanoparticles: applications and future perspective-A review. J PhotochemPhotobiolB. 2018;189:234–243. doi:10.1016/j.jphotobiol.2018.10.022
  • Liang J, Li F, Fang Y, et al. Cytotoxicity and apoptotic effects of tea polyphenol-loaded chitosan nanoparticles on human hepatoma HepG2 cells. Mater Sci Eng C Mater BiolAppl. 2014;36:7–13. doi:10.1016/j.msec.2013.11.039
  • Iqbal M, Usanase G, Oulmi K, et al. Preparation of gold nanoparticles and determination of their particles size via different methods. Mater Res Bull. 2016;79:97–104. doi:10.1166/jcsb.2015.1127
  • Safer A-M. Emerging possibilities of green tea as a potential treatment regimen for hepatic fibrosis. Global J Nanomed. 2017;2:1–6.
  • Li W, Yalcin M, Lin O, Ardawi M-SM, Mousa SA. Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery. J Control Release. 2017;248:117–124. doi:10.1016/j.jconrel.2017.01.00928077264
  • Yin Y, Cui L, Yan F, Zhang Z, Li W, Wang L. Epigallocatechin gallate based magnetic gold nanoshells nanoplatform for cancer theranostic applications. J Mater Chem B. 2017;5(3):454–463. doi:10.1039/C6TB02408D
  • Yang R, Liu Y, Gao Y, Wang Y, Blanchard C, Zhou Z. Ferritin glycosylated by chitosan as a novel EGCG nano-carrier: structure, stability, and absorption analysis. Int J Biol Macromol. 2017;105:252–261. doi:10.1016/j.ijbiomac.2017.07.04028693994
  • Safer A-MA, Hanafy NA, Bharali DJ, Cui H, Mousa SA. Effect of green tea extract encapsulated into chitosan nanoparticles on hepatic fibrosis collagen fibers assessed by atomic force microscopy in rat hepatic fibrosis model. J Nanosci Nanotechnol. 2015;15(9):6452–6459. doi:10.1166/jnn.2015.1060826716199
  • Chen YC, Yu SH, Tsai GJ, Tang DW, Mi FL, Peng YP. Novel technology for the preparation of self-assembled catechin/gelatin nanoparticles and their characterization. J Agric Food Chem. 2010;58(11):6728–6734. doi:10.1021/jf100511620476739
  • Dube A, Nicolazzo JA, Larson I. Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate. Eur J Pharm Sci. 2010;41(2):219–225. doi:10.1016/j.ejps.2010.06.01020600878
  • Fan W, Yan W, Xu Z, Ni H. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B Biointerfaces. 2012;90:21–27. doi:10.1016/j.colsurfb.2011.09.04222014934
  • Hu B, Ting Y, Yang X, Tang W, Zeng X, Huang Q. Nano chemo prevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. ChemCommun (camb). 2012;48(18):2421–2423. doi:10.1039/c2cc17295j
  • Liang J, Cao L, Zhang L, Wan X-C. Preparation, characterization, and in vitro antitumor activity of folate conjugated chitosan coated EGCG nanoparticles. Food Sci Biotechnol. 2014;23(2):569–575. doi:10.1007/s10068-014-0078-4
  • Liang J, Yan H, Puligundla P, Gao X, Zhou Y, Wan X. Applications of chitosan nanoparticles to enhance absorption and bioavailability of tea polyphenols: a review. Food Hydrocoll. 2017;69:286–292. doi:10.1016/j.foodhyd.2017.01.041
  • Hu B, Ting Y, Zeng X, Huang Q. Cellular uptake and cytotoxicity of chitosan-case in phosphopeptides nanocomplexes loaded with epigallocatechin gallate. CarbohydrPolym. 2012;89(2):362–370. doi:10.1016/j.carbpol.2012.03.015
  • Ramkumar Ponnuraj JK, Gopalakrishnan S, Senthilnathan K, Meganathan V, Saravanan P. Formulation and characterization of epigallocatechin gallate nanoparticles. Am J Pharm Res. 2015;5(01). doi:10.1044/1980-iajpr.150122
  • Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Method. 2012;9(7):671–675. doi:10.1038/nmeth.2089
  • Bhumkar DR, Joshi HM, Sastry M, Pokharkar VB. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res. 2007;24:1415–1426. doi:10.1007/s11095-007-9257-917380266
  • Liu F, Majeed H, Antoniou J, et al. pH and temperature stability of (-)-epigallocatechin-3-gallate-beta-cyclodextrin inclusion complex-loaded chitosan nanoparticles. Carbohydr Polym. 2016;149:340–347. doi:10.1016/j.carbpol.2016.04.10027261758
  • Fernandes Queiroz M, Karoline R, Melo T, Sabry DA, Lanzi SG, Oliveira Rocha HA. Does the use of Chitosan contribute to oxalate kidneystone formation? Mar Drugs. 2015;13:141–158. doi:10.3390/md13010141
  • Manikandan M, Kannan K, Manavalan R. Compatibility studies of camptothecin with various pharmaceutical excipients used in the development of nanoparticle formulation. Int J Pharm Pharm Sci. 2013;5:315–321.
  • Safer A-M. A quantitative description of lipid and extracellular matrix proteinaceous fibers in hepatic fibrosis of a rat model by imagej using nano-images. J Text Sci Eng. 2017;08:03. doi:10.4172/2157-7439.1000446